title: Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection.
authors.affiliation: Division of Thoracic Surgery, Otto Wagner Hospital, Vienna, Austria. s.watzka@utanet.at
authors.forename: Stefan B
authors.initials: SB
authors.lastname: Watzka
authors.forename: Irene
authors.initials: I
authors.lastname: Rauscher-Pötsch
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Stubenberger
authors.forename: Vlad
authors.initials: V
authors.lastname: Getman
authors.forename: Ulrike
authors.initials: U
authors.lastname: Setinek
authors.forename: Martin
authors.initials: M
authors.lastname: Tötsch
authors.forename: Ulrike
authors.initials: U
authors.lastname: Pötschger
authors.forename: Michael R
authors.initials: MR
authors.lastname: Müller
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000378:metabolism*; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D016896:Treatment Outcome; D000099200:Scaffold Protein ILK
chemical_list: D014408:Biomarkers, Tumor; D017346:Protein Serine-Threonine Kinases; D000099200:Scaffold Protein ILK